Loawan, Aspiya H.
HRN: 22-57-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2023
CEFTRIAXONE 1G (VIAL)
02/06/2023
02/13/2023
IV
520mg
OD
CHD
Waiting Final Action
Indication: Empiric Type of Infection: Cardiovascular Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes